In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.
Nuclear transplantation can reprogramme a somatic genome back into an embryonic epigenetic state, and the reprogrammed nucleus can create a cloned animal or produce pluripotent embryonic stem cells. One potential use of the nuclear cloning approach is the derivation of 'customized' embryonic stem (ES) cells for patient-specific cell treatment, but technical and ethical considerations impede the therapeutic application of this technology. Reprogramming of fibroblasts to a pluripotent state can be induced in vitro through ectopic expression of the four transcription factors Oct4 (also called Oct3/4 or Pou5f1), Sox2, c-Myc and Klf4. Here we show that DNA methylation, gene expression and chromatin state of such induced reprogrammed stem cells are similar to those of ES cells. Notably, the cells-derived from mouse fibroblasts-can form viable chimaeras, can contribute to the germ line and can generate live late-term embryos when injected into tetraploid blastocysts. Our results show that the biological potency and epigenetic state of in-vitro-reprogrammed induced pluripotent stem cells are indistinguishable from those of ES cells.
Pubmed ID: 17554336 RIS Download
Animals | Cell Differentiation | Cell Lineage | Chimera | Chromatin | DNA Methylation | DNA-Binding Proteins | Female | Fibroblasts | Gene Silencing | Homeodomain Proteins | Male | Mice | Nanog Homeobox Protein | Octamer Transcription Factor-3 | Pluripotent Stem Cells | Teratoma